Article abstract
Nature Medicine 14, 1236 - 1246 (2008)
Published online: 19 October 2008 | doi:10.1038/nm.1877
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
Masatoshi Jinnin1, Damian Medici1, Lucy Park1, Nisha Limaye2, Yanqiu Liu1, Elisa Boscolo3, Joyce Bischoff3, Miikka Vikkula2, Eileen Boye1 & Bjorn R Olsen1
Abstract
Infantile hemangiomas are localized and rapidly growing regions of disorganized angiogenesis. We show that expression of vascular endothelial growth factor receptor-1 (VEGFR1) in hemangioma endothelial cells (hemECs) and hemangioma tissue is markedly reduced compared to controls. Low VEGFR1 expression in hemECs results in VEGF-dependent activation of VEGFR2 and downstream signaling pathways. In hemECs, transcription of the gene encoding VEGFR1 (FLT1) is dependent on nuclear factor of activated T cells (NFAT). Low VEGFR1 expression in hemECs is caused by reduced activity of a pathway involving 
1 integrin, the integrin-like receptor tumor endothelial marker-8 (TEM8), VEGFR2 and NFAT. In a subset of individuals with hemangioma, we found missense mutations in the genes encoding VEGFR2 (KDR) and TEM8 (ANTXR1). These mutations result in increased interactions among VEGFR2, TEM8 and 1 integrin proteins and in inhibition of integrin activity. Normalization of the constitutive VEGFR2 signaling in hemECs with soluble VEGFR1 or antibodies that neutralize VEGF or stimulate 1 integrin suggests that local administration of these or similar agents may be effective in hemangioma treatment.
- Department of Developmental Biology, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, Massachusetts 02115, USA.
- Human Molecular Genetics, de Duve Institute, Avenue Hippocrate 74, Universite Catholique de Louvain, Brussels B-1200, Belgium.
- Vascular Biology Program, Department of Surgery, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.
Correspondence to: Bjorn R Olsen1 e-mail: bjorn_olsen@hms.harvard.edu
Correspondence to: Eileen Boye1 e-mail: eileen_boye@hms.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasionOncogene Original Article
Infantile hemangiomas are arrested in an early developmental vascular differentiation stateModern Pathology Original Article
See all 12 matches for Research
